Catalyst Calendar - March 23, 2026 (EOD)

 ## Today's Catalyst Results How did scheduled events play out? - **Federal Reserve Interest Rate Decision** - Result: The Fed held interest rates steady, maintaining the current policy stance amid mixed economic signals. Market reaction: The S&P 500 rallied 1.32% to close at $657.16, the Nasdaq 100 gained 1.36% to $589.98, and the Dow Jones rose 1.57% to $463.05, reflecting investor relief and optimism. - **Corporate Earnings Reports** - Result: Mixed earnings with notable beats and misses. For example, **Dell (DELL)** surged 4.39% following strong AI backlog commentary, while **Eli Lilly (LLY)** was up modestly 0.42% despite litigation concerns. Market reaction: Tech and industrial sectors led gains, supported by positive earnings momentum. - **Oil Market Reaction to Geopolitical Tensions** - Result: Oil prices plunged 8.59% to $111.00 on easing Iran conflict threats after Trump postponed strikes. Market reaction: Energy stocks showed mixed performance; **Cheniere Energy (LNG)** was slightly up 2.25%, while overall oil volatility pressured related sectors. - **Gold Prices** - Result: Gold fell 1.57% to $406.90 amid reduced safe-haven demand as geopolitical tensions eased. Market reaction: Precious metals miners declined, reflecting the drop in bullion prices. ## Surprise News Today Unexpected developments that moved markets: - **$APGE (Apogee Therapeutics)** - Shares surged 19.78% following positive Phase 2 data for Zumilokibart in atopic dermatitis, signaling strong clinical progress and investor enthusiasm. - **$BNGO (Bionano Genomics)** - Jumped 30.42% on earnings transcript highlights and renewed investor interest in its genomic mapping technology. - **$SATL (Satellogic Inc.)** - Soared 35.93% after Q4 earnings call, reflecting optimism about satellite imaging growth prospects. - **$ALHC (Alight Inc.)** - Rose 8.30% after CEO stock sales were disclosed, interpreted as insider confidence in the company’s outlook. - **$BLRX (BioLineRx Ltd.)** - Dropped 12.45% due to clinical trial delays and cautious sentiment around pipeline progress. - **$SEDG (SolarEdge Technologies)** - Fell 9.55% despite broader market rally, likely due to profit-taking after recent strong performance and sector rotation. ## After-Hours Catalysts Earnings and events happening tonight: - **$PFE (Pfizer)** - Watch for updates on Lyme disease vaccine candidate FDA approval plans following a recent trial miss but positive regulatory signals. - **$ADBE (Adobe)** - Monitor for leadership transition details and guidance revisions after a downgrade by Barclays. - **$HPE (Hewlett Packard Enterprise)** - Expect commentary on AI adoption acceleration and cloud services growth. - **$MSFT (Microsoft)** - Market will focus on any updates regarding AI initiatives and OpenAI partnership developments. - **$META (Meta Platforms)** - Investors await further insights on AI integration and advertising revenue trends. - **$GEV (GE Vernova)** - After strong turbine pricing commentary, watch for additional guidance on electrification demand. ## Tomorrow's Calendar Key events scheduled for tomorrow: - **Bank of America (BAC) Earnings** - Time: Pre-market - Watch for: Revenue growth and margin outlook amid rising interest rates. - **American Airlines (AAL) Earnings** - Time: Pre-market - Watch for: Fuel cost impact and capacity guidance given recent oil price volatility. - **Simon Property Group (SPG) Proxy Statement** - Time: N/A - Watch for: Governance updates following CEO David Simon’s passing. - **Midland States Bancorp Proxy Statement** - Time: N/A - Watch for: Board and management changes. - **Opus Genetics Proxy Statement** - Time: N/A - Watch for: Corporate governance and strategic direction. - **Guidewire Software Form 144 Filing** - Time: N/A - Watch for: Insider selling activity and potential impact on stock sentiment. ## This Week Ahead Other catalysts coming this week (only if dates mentioned): - Monday: Senate to take final vote on Mullin's DHS secretary appointment. - Monday: Earnings calls from Caledonia Mining, Thungela Resources, and others. - Monday: JPMorgan to kick off $8 billion junk-bond sale for EA buyout. - Monday: Earnings call transcripts from multiple companies including Quarterhill and NRx Pharmaceuticals. ## Highest Conviction Setup Based on today's action and upcoming catalysts: - Stock: **$APGE (Apogee Therapeutics)** - Catalyst: Positive Phase 2 clinical data for Zumilokibart in moderate to severe atopic dermatitis. - Thesis: The strong clinical results and nearly 20% jump in share price highlight significant upside potential as Apogee positions itself as a disruptor in dermatology therapeutics. The upcoming earnings call and analyst attention further support momentum for this biotech stock. --- Overall, the market showed resilience with strong gains in major indices driven by easing geopolitical tensions and solid corporate earnings. Key themes include AI adoption in tech, energy sector volatility amid oil price swings, and selective biotech breakthroughs. Investors should monitor tomorrow’s earnings and proxy filings for further directional cues.